Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials.
BMC Psychiatry
; 22(1): 141, 2022 02 22.
Article
in En
| MEDLINE
| ID: mdl-35193545
Full text:
1
Database:
MEDLINE
Main subject:
Disorders of Excessive Somnolence
/
Narcolepsy
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
BMC Psychiatry
Journal subject:
PSIQUIATRIA
Year:
2022
Type:
Article
Affiliation country:
Japan